1
|
Morpho-Physiological and Molecular Characterization Reveal Low Genetic Variation for Conservation of Endangered Iranian Moshgak (Ducrosia anethifolia Boiss). Biochem Genet 2022; 60:2587-2610. [PMID: 35668340 DOI: 10.1007/s10528-022-10237-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Accepted: 05/18/2022] [Indexed: 11/02/2022]
Abstract
Ducrosia anethifolia Boiss is an aromatic vegetable and medicinal plant of Apiaceae family. In this study, morphological and essential oil studies as well as ISSR analyses were employed to investigate genetic diversity in 120 Moshgak accessions of 24 Iranian populations. High variations were observed in morpho-physiological traits (morphological and essential oil contents) of the populations in 2 consecutive agronomic years. In both studied years, the highest leaf (1% and 1.2%) and seed (2.46% and 2.9%) essential oil contents were recorded for the Abarkuh population. For ISSR analysis, 15 primer combinations were employed that produced 120 polymorphic bands. Dendrogram and STRUCTURE software grouped the accessions into four clusters although such grouping did not fit the geographic regions perfectly. Among the populations, Abarkuh and Kerman exhibited the highest genetic distance. Based on analysis of molecular variance (AMOVA), only 4.32% of the total genetic diversity was observed among the populations, while 95.68% was detected within the populations. Moreover, the studied populations exhibited a low genetic differentiation (Gst = 0.13) but a high gene flow (Nm = 3.26). It may be concluded that the results of the study provide new insights regarding the genetic diversity of Moshgak germplasm that will be useful for its conservation management and breeding programs for oil- and yield-related traits.
Collapse
|
2
|
Dirar AI, Adhikari-Devkota A, Kunwar RM, Paudel KR, Belwal T, Gupta G, Chellappan DK, Hansbro PM, Dua K, Devkota HP. Genus Blepharis (Acanthaceae): A review of ethnomedicinally used species, and their phytochemistry and pharmacological activities. JOURNAL OF ETHNOPHARMACOLOGY 2021; 265:113255. [PMID: 32798615 DOI: 10.1016/j.jep.2020.113255] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/21/2020] [Revised: 07/31/2020] [Accepted: 08/04/2020] [Indexed: 06/11/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Blepharis is an Afro-Asiatic genus belonging to the family Acanthaceae. It comprises about 126 species that occur in arid and semi-arid habitats. Some species of Blepharis are used in traditional medicines in different countries mainly for their anti-inflammatory, wound healing activities along with treatment of gastrointestinal disorders and bone fractures. AIM OF THE REVIEW The present review aims to collate and analyze the available data and information on distribution, traditional uses, chemical constituents and pharmacological activities of Blepharis. METHODS Scientific information of genus Blepharis was retrieved from the online bibliographic databases such as MEDLINE/PubMed, SciFinder, Web of Science and Google Scholar and secondary resources including books and proceedings. RESULTS Seven species of Blepharis were found to be reported frequently as useful in folklore in African and Asian countries. B. maderaspatensis was found to be widely used in Indian traditional medicines whereas the B. ciliaris and B. edulis were common in folklore of Egypt, Jordan, and Arabia. Active phytochemicals of Blepharis are flavonoids from B. ciliaris, alkaloids from B. sindica, phenolic acid derivatives, and phytosterols, and derivatives of hydroxamic acids from B. edulis resulted in possessing diverse biological properties such as anti-microbial, anti-inflammatory, and anti-cancer. CONCLUSIONS Various species of Blepharis were found to be used in traditional medicine systems in African and Asian countries. Few of these species were studied for their bioactive chemical constituents however the activity guided isolation studies are not performed. Similarly, detailed pharmacological studies in animal models to explore their mechanism of action are also not reported. Future studies should focus on these aspects related to the medicinally used species of Blepharis. The detailed and comprehensive comparative analysis presented here gives valuable information of the currently used Blepharis species and pave the way to investigate other useful species of Blepharis pertaining to ethnobotany, phytochemistry and discovery of new drugs.
Collapse
Affiliation(s)
- Amina Ibrahim Dirar
- Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, Kumamoto, 862-0973, Japan; Medicinal, Aromatic Plants and Traditional Medicine Research Institute (MAPTRI), National Center for Research, P.O. Box 2404, Mek Nimr Street, Khartoum, Sudan; Faculty of Clinical and Industrial Pharmacy, National University-Sudan, P.O. Box 3783, Al-Raki Area, Khartoum, Sudan
| | - Anjana Adhikari-Devkota
- Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, Kumamoto, 862-0973, Japan
| | | | - Keshav Raj Paudel
- Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW 2007, Australia
| | - Tarun Belwal
- Key Laboratory for Agro-Products Postharvest Handling of Ministry of Agriculture and Rural Affairs, Zhejiang Key Laboratory for Agro-Food Processing, College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058, China
| | - Gaurav Gupta
- School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India
| | - Dinesh Kumar Chellappan
- Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia
| | - Philip Michael Hansbro
- Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia; Faculty of Science, University of Technology Sydney, Ultimo, NSW 2007, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, 2308, Australia
| | - Kamal Dua
- Centre for Inflammation, Centenary Institute, Sydney, NSW 2050, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, 2308, Australia; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia
| | - Hari Prasad Devkota
- Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, Kumamoto, 862-0973, Japan; Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program, 5-1 Oe-honmachi, Chuo-ku, Kumamoto, 862-0973, Japan.
| |
Collapse
|